| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 27, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 24, 2013 | S&P Capital IQ Quantitative Report | N/A | Keryx Biopharmaceuticals | 6 | $69 | | May 24, 2013 | Pechala's Reports | Frantisek Pechala | KERYX BIOPHARMACEUTICALS INC (KERX) 12-months forecast | 1 | $15 | | May 23, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: BIOD , INFI , KERX , SNTA -- DRUGS | 3 | $34.50 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: KERYX BIOPHARM -- KERX | 1 | $11.50 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for KERX | 11 | $126.50 | | May 18, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: KERYX BIOPHARMACEUTICALS INC | 5 | $10 | | May 15, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Keryx Biopharmaceuticals, Inc. | 41 | $471.50 | | May 13, 2013 | Zacks Investment Research Inc. | N/A | KERYX BIOPHARMA (KERX) Zacks Company Snapshot | 1 | $11.50 |
|
View All Reports for KERX ... |
|
|
0.00 (0.02%) May 24, 4:35PM EDT